Using the EngagedMD Multimedia Platform to Improve Informed Consent for Ovulation Induction, Intrauterine Insemination, and In Vitro Fertilization by Madeira, Jody L. et al.
Maurer School of Law: Indiana University 
Digital Repository @ Maurer Law 
Articles by Maurer Faculty Faculty Scholarship 
12-2018 
Using the EngagedMD Multimedia Platform to Improve Informed 
Consent for Ovulation Induction, Intrauterine Insemination, and In 
Vitro Fertilization 
Jody L. Madeira 
Indiana University Maurer School of Law, jmadeira@indiana.edu 
Jennifer Rehbein 
Wright State University 
Mindy S. Christianson 
Johns Hopkins University 
Miryoung Lee 
University of Texas Health Science Center at Houston 
J. Preston Parry 
Positive Steps Fertility 
See next page for additional authors 
Follow this and additional works at: https://www.repository.law.indiana.edu/facpub 
 Part of the H alth Information Technology Commons, Health Law and Policy Commons, Obstetrics 
and Gynecology Commons, Reproductive and Urinary Physiology Commons, Science and Technology Law 
Commons, and the Women's Health Commons 
Recommended Citation 
Madeira, Jody L.; Rehbein, Jennifer; Christianson, Mindy S.; Lee, Miryoung; Parry, J. Preston; Pennings, 
Guido; and Lindheim, Steven R. MD, "Using the EngagedMD Multimedia Platform to Improve Informed 
Consent for Ovulation Induction, Intrauterine Insemination, and In Vitro Fertilization" (2018). Articles by 
Maurer Faculty. 2978. 
https://www.repository.law.indiana.edu/facpub/2978 
This Article is brought to you for free and open access by 
the Faculty Scholarship at Digital Repository @ Maurer 
Law. It has been accepted for inclusion in Articles by 
Maurer Faculty by an authorized administrator of Digital 
Repository @ Maurer Law. For more information, please 
contact rvaughan@indiana.edu. 
Authors 
Jody L. Madeira, Jennifer Rehbein, Mindy S. Christianson, Miryoung Lee, J. Preston Parry, Guido Pennings, 
and Steven R. Lindheim MD 
This article is available at Digital Repository @ Maurer Law: https://www.repository.law.indiana.edu/facpub/2978 
Using the EngagedMD multimedia
platform to improve informed consent
for ovulation induction, intrauterine
insemination, and in vitro fertilization
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J. Preston Parry, M.D.,e Guido Pennings, Ph.D.,f and Steven R. Lindheim, M.D., M.M.M.b
a Maurer School of Law, Indiana University, Bloomington, Indiana; b Department of Obstetrics and Gynecology, Wright
State University, Boonshoft School of Medicine, Dayton, Ohio; c Department of Gynecology and Obstetrics, Johns
Hopkins University School of Medicine, Baltimore, Maryland; d Department of Epidemiology, Human Genetics, and
Environmental Sciences, University of Texas Health Science Center at Houston, School of Public Health, Brownsville,
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Science, Ghent University, Blandijnberg, Gent, Belgium
Objective: To study patient and provider feedback on how a multimedia platform (EngagedMD) helps patients to understand the risks
and consequences of in vitro fertilization (IVF), ovulation induction (OI), and intrauterine insemination (IUI) treatments and the impact
of the informed consent process.
Design: Prospective survey study.
Setting: IVF units in the United States.
Patient(s): Six-thousand three-hundred and thirty-three patients who viewed the multimedia platform before IVF or OI-IUI treatment
at 13 U.S. IVF centers and 128 providers.
Intervention(s): Quantitative survey with 17 questions.
Main Outcome Measure(s): Assessment of the impact of a multimedia platform on patient anxiety, comprehension, and satisfaction
and provider/nurse feedback related to the informed consent process.
Result(s): The survey was completed by 3,097 respondents (66% IVF treatment; 34% OI-IUI treatment) and 44 providers. Overall, 93%
felt the media platform was intuitive, and 90% and 95% felt it had appropriate duration and detail, respectively. Most agreed/strongly
agreed it better prepared them to consent (88%), increased their comfort in pursuing treatment (77%) and increased their satisfaction
with their care (83%). Compared with the OI-IUI group, statistically significantly more participants who viewed the IVF media platform
strongly agreed that the comprehension questions reinforced key concepts (47% vs. 40%), educated them about treatment risks (55% vs.
44%), helped them ask providers informed questions (45% vs. 36%), and better prepared them to sign consent forms (46% vs. 37%).
Overall, 63% of providers felt that the media platform improved patient learning, made patients more accountable, and
standardized information dissemination.
Conclusion(s): The EngagedMD media platform improves patient knowledge, satisfaction, and control over medical decision making
and better prepares patients to give informed consent. Furthermore, it is well-liked by providers and is easily implemented. (Fertil Steril
2018;110:1338–46. 2018 by American Society for Reproductive Medicine.)
El resumen está disponible en Español al final del artículo.
Key Words: Assisted reproductive technology, informed consent, in vitro fertilization, multimedia platform
Discuss: You can discuss this article with its authors and other readers at https://www.fertstertdialog.com/users/16110-fertility-
and-sterility/posts/37730-26186
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I nformed consent within the context of assisted reproduc-tion technology (ART) poses unique ethical, medical, andlegal challenges because these treatments are intended
to create offspring. The risks, benefits, side effects, and alter-
natives of ART often bear little resemblance to those in other
practice areas—including the legal consequences of establish-
ing and relinquishing parental rights. With each medical
advance in ART, informed consent for the associated thera-
pies becomes more difficult, and the discussions grow
increasingly complex (1, 2).
The American Society for Reproductive Medicine (ASRM)
has created a model template for informed consent (3). How-
ever, many reproductive endocrinologists, mental health pro-
fessionals, and attorneys have expressed concern over
whether patients actually understand and balance ART's
risks, benefits, side effects, and alternatives. Furthermore,
often patients find the ART consent process overwhelming
or disregard it as unimportant, which undermines their recall
and comprehension (3–5).
In other disciplines, medical practitioners have employed
a variety of multimedia patient education and consent tools to
improve patients' comprehension (1, 2). These tools range
from DVDs to narrated computer applications and computer
tutorials complete with quizzes, which can be accessed in
clinical settings or from personal computers or mobile
devices (4). Older studies of multimedia aids have yielded
equivocal results regarding their superiority to traditional
paper consent materials because poorly designed aids (e.g.,
those that are tedious or too long) can negatively impact
patient education (4–7). More recent randomized studies
have linked multimedia interventions to greater patient
enjoyment; improved patient knowledge, comprehension,
and recall; improved physician–patient relationships; lower
anxiety; and faster learning (8, 9). The interactive format of
multimedia interventions has been found to increase patient
comprehension and enjoyment (1). These presentations have
also been described as ensuring consistency across
providers and patients, potentially decreasing the feeling
that consent is a bureaucratic routine, and simultaneously
encouraging patients to be more involved with their care (8).
EngagedMD, a commercially available multimedia plat-
form, was designed to supplement communication among
physicians, nurses, support staff, and patients, with data
collected frommultiple representatives of each of these stake-
holders via online surveys and in-person and phone inter-
views. Using that information, a beta (usable prototype)
version of the platform was launched in December 2014.
This particular media platform allows patients to watch
customizable educational video modules that cover the topics
of in vitro fertilization (IVF), ovulation induction (OI), and in-
trauterine insemination (IUI) treatments, followed by short
comprehension quizzes. The modules were developed in
collaboration with each of the stakeholder groups to create
outlines of what topics should be covered. Using established
consent forms from the Society for Assisted Reproductive
Technology (SART), a script was created covering each topic,
and live shots were filmed and paired with a professional voi-
ceover reading the information that physician consultants
deemed necessary in solicited feedback.
Before a module went live, the physicians at each practice
reviewed and accepted it; if necessary, they could make ad-
justments to the module to ensure alignment with the prac-
tice's needs. The providers could track the patients' progress
and quiz responses to ascertain where the patients might
need additional information. The objective of our study was
to examine the impact of a multimedia platform on patient
anxiety, comprehension, and satisfaction as well as pro-
vider/nurse feedback related to the informed consent process.
MATERIALS AND METHODS
This prospective survey study was reviewed and approved by
the Indiana University-Bloomington human subjects institu-
tional review board, and the study was in compliance with
privacy act guidelines (5). Links to a 17-question electronic
survey were sent to English-speaking patients whose pro-
viders had assigned them to the multimedia platform before
undergoing OI-IUI or IVF at one of 13 fertility clinics imple-
menting the multimedia platform from October 2015 to
March 2017. All patients who completed the media platform
modules (IVF or OI-IUI) were given the option to complete
the survey regardless of completion of treatment. By March
2017, a total of 13 IVF programs in the United States had im-
plemented the multimedia platform into their patient educa-
tion process. Three were academic programs, and 10 were
private clinics, of which five were located on the East Coast,
five in the Midwest, and three on the West Coast. The practice
sizes were diverse: seven performed <500 IVF cycles/year,
two performed between 500 and 999 IVF cycles/year, and
four performed>1,000 IVF cycles/year. Each program imple-
mented the media platform at its own discretion (either after
the initial consult or before/after the patient's teaching/
educational session).
The survey was not originally created for the purpose of
publishing the results; rather, it was designed to assess patient
and provider/nurse feedback and opinions regarding the me-
dia platform's impact on perceived comprehension and satis-
faction as related to the informed consent process. For this
reason, obtaining demographic information from respon-
dents was not part of the initial design. The Likert item re-
sponses were scaled as follows: 1, strongly disagree; 2,
disagree; 3, neutral; 4, agree; and 5, strongly agree. The ques-
tionnaires also included both closed and open-ended ques-
tions that allowed for comments.
Multimedia Platform
The multimedia platform consists of customizable educa-
tional video modules 5 to 7 minutes in length covering IVF,
OI, and IUI treatments written and voiced over in English at
a 10th grade comprehension level (Fig. 1). To use the platform,
both the patient and the practice need access to a computer,
phone, or tablet with broadband Internet. There are no other
technical requirements. Each video is followed by a brief
matching quiz, during which an incorrect answer triggers a
pop-up screen with the correct answer. The IVF modules
(including quiz questions) can be completed in approximately
1 hour and 20minutes; the OI-IUI module can be completed in
50 minutes. Patients also can submit questions to their
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medical teams, who can see the patients' completion progress,
quiz results, and questions through a ‘‘backdoor.’’ This allows
providers to customize their consent conversations to the pa-
tients' individual needs. After completing the media platform,
the patients can either sign hard copies or e-sign electronic
copies of informed consent documents (specific to each IVF
program) before initiating treatment, but the workflow for
implementing affirmation of consent is program specific
(Supplemental Data, available online).
During platform design and development, the company
consulted (and continues to consult) with attorneys who
specialize in ART to ensure that its content is legally accurate
and meets the state law requirements in the states where the
clients are located. (State laws rarely regulate matters such
as embryo disposition, with notable exceptions including
Louisiana and Arizona.) Since the initial launch, the platform
has been continually revised based on user feedback to ensure
its alignment with each practice's needs.
Moreover, it is generally accepted that electronic sig-
natures and records have legal force in clinical research
and medical treatment. The federal E-SIGN Act gives elec-
tronic signatures legal force if all contracting parties
choose to use electronic documents and electronic signa-
tures. A prior ‘‘model’’ law, the Uniform Electronic Trans-
actions Act (‘‘UETA’’) (widely adopted in 47 states, the
District of Columbia, and the U.S. Virgin Islands), stated
that when a signature or record is legally required, an elec-
tronic version can be used when the parties agree to use
electronic forms. Records of electronic signatures must be
kept under both E-SIGN Act and UETA. Moreover, in clin-
ical trials, the federal Office for Human Research Protec-
tions and the U.S. Food and Drug Administration
regulations permit the use of electronic signatures when
written informed consent is required.
Patients
In all, 14,028 patients completed the media platform modules
during the time period, and 6,333 patients/partners (45.1%)
completed the survey from 13 fertility clinics. Because some
data were missing for five key survey questions, we decided
to include a total of 3,097 patients/partners (49%, of 6,333
FIGURE 1
Screenshot of the front page of the EngagedMD media platform (https://engaged-md.com).
Madeira. Informed consent with multimedia platform. Fertil Steril 2018.
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TABLE 1












n (%) P value
Did the program answer any
questions that you otherwise
would have had to ask your
medical team?
3,097
No, it did not answer any
questions.
179 (5.8) 80 (5.2) 99 (6.4) .165 97 (4.7) 82 (7.8) < .001
Yes, it answered one or a few
questions.
1,390 (44.9) 714 (46.3) 676 (43.5) 811 (39.6) 579 (55.1)
Yes, it answered many questions. 1,528 (49.3) 749 (48.5) 779 (50.1) 1,138 (55.6) 390 (37.1)
Did you like learning about your
procedure from the eLearning
system?
3097
No 151 (4.9) 79 (5.1) 72 (4.6) .529 95 (4.6) 56 (5.3) .402
Yes 2,946 (95.1) 1,464 (94.9) 1,482 (95.4) 1,951 (95.4) 995 (94.7)
Do you feel that the educational
videos you saw as part of this
program were a helpful
addition to your consultations
with your medical team?
3,097
No 96 (3.1) 44 (2.9) 52 (3.4) .427 49 (2.4) 47 (4.5) .002
Yes 3,001 (96.9) 1,499 (97.2) 1,502 (96.7) 1,997 (97.6) 1,004 (95.5)
How important is it that you are
properly educated about your
care?
3,094
Not at all important 3 (0.1) 2 (0.1) 1 (0.1) .340a 3 (0.2) 0 (0) < .001a
Not important 4 (0.1) 4 (0.3) 0 (0) 3 (0.2) 1 (0.1)
Neutral 34 (1.1) 18 (1.2) 16 (1) 20 (1.0) 14 (1.3)
Important 457 (14.8) 228 (14.8) 229 (14.7) 257 (12.6) 200 (19)
Very Important 2,599 (83.9) 1,291 (83.7) 1,308 (84.2) 1,763 (86.2) 836 (79.5)
Learning about my procedure from
the eLearning system made
me:
3,097
Less satisfied with my care. 36 (1.2) 16 (1) 20 (1.3) .313 25 (1.2) 11 (1.1) .613
Neither more or less satisfied with
my care.
826 (26.7) 429 (27.8) 397 (25.6) 535 (26.2) 291 (27.7)
More satisfied with my care. 2,235 (72.2) 1,098 (71.2) 1,137 (73.2) 1,486 (72.6) 749 (71.3)
The comprehension questions
helped reinforce key concepts.
2,663
Strongly disagree 38 (1.4) 13 (1) 25 (1.9) .588a 23 (1.3) 15 (1.6) .002a
Disagree 40 (1.5) 23 (1.7) 17 (1.3) 27 (1.5) 13 (1.4)
Neutral 203 (7.6) 108 (8.0) 95 (7.2) 130 (7.4) 73 (8.0)
Agree 1,200 (45.1) 614 (45.5) 586 (44.6) 751 (43.0) 449 (49.1)
Strongly agree 1,182 (44.4) 591 (43.8) 591 (45) 817 (46.7) 365 (39.9)
The software was intuitive to use. 2,661
Strongly disagree 37 (1.4) 15 (1.1) 22 (1.7) .462a 25 (1.4) 12 (1.3) .210a
Disagree 20 (0.8) 7 (0.5) 13 (1) 19 (1.1) 1 (0.1)
Neutral 132 (5) 64 (4.8) 68 (5.2) 89 (5.1) 43 (4.7)
Agree 1,068 (40.1) 544 (40.5) 524 (39.8) 669 (38.4) 399 (43.5)
Strongly agree 1,404 (52.8) 715 (53.2) 689 (52.4) 942 (54) 462 (50.4)
The level of detail in the videos was: 2,699
Not detailed enough. 7 (0.3) 2 (0.2) 5 (0.4) .504 4 (0.2) 3 (0.3) .771
The appropriate level of detail. 2,421 (89.7) 1,225 (89.7) 1,196 (89.7) 1,586 (89.5) 835 (90.1)
Too detailed. 271 (10) 138 (10.1) 133 (10) 182 (10.3) 89 (9.6)
The videos were: 2,699
Too short. 60 (2.2) 33 (2.42) 27 (2.02) .577 36 (2) 24 (2.6) .149
The appropriate length for my
need.
2,553 (94.6) 1,285 (94.14) 1,268 (95.05) 1,672 (94.4) 881 (95)
Too long. 86 (3.2) 47 (3.44) 39 (2.92) 64 (3.6) 22 (2.4)
The eLearning module.
Educated me about the risks
associated with treatment.
2,695
Strongly disagree 63 (2.3) 30 (2.2) 33 (2.5) .237a 38 (2.2) 25 (2.7) < .001a
Disagree 10 (0.4) 6 (0.4) 4 (0.3) 8 (0.5) 2 (0.2)
Neutral 114 (4.2) 52 (3.8) 62 (4.7) 60 (3.4) 54 (5.8)
Madeira. Informed consent with multimedia platform. Fertil Steril 2018.
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survey questionnaires) in the analysis (Table 1). These key
questions included ‘‘Did the EngagedMD program answer
any questions that you otherwise would have had to ask
your medical team?’’; ‘‘Did you like learning about your pro-
cedure from the EngagedMD eLearning system?’’; ‘‘Do you
feel that the educational videos you saw as part of this pro-
gram were a helpful addition to your consultations with
your medical team?’’; ‘‘How important is it that you are prop-
erly educated about your care?’’; and ‘‘Learning about my
procedure from the eLearning system made me [less satisfied
with my care/neither more or less satisfied with my care/more
satisfied with my care].’’ In addition, the 41 providers (34% of
120 survey participants) who responded were included in the
analysis. To protect participant confidentiality, each partici-
pant was assigned a unique identification (ID) number that
was used on all data collection forms, in statistical analyses,
and for academic scholarship.
Statistics
All statistical analyses were conducted using SAS for Win-














n (%) P value
Agree 1,128 (41.9) 600 (43.9) 528 (39.8) 688 (38.9) 440 (47.5)
Strongly agree 1,380 (51.2) 680 (49.7) 700 (52.8) 975 (55.1) 405 (43.7)
Enhanced my ability to ask
informed questions of my
medical team.
2,693
Strongly disagree 61 (2.3) 28 (2.1) 33 (2.5) .727a 35 (2) 26 (2.8) < .001a
Disagree 25 (0.9) 11 (0.8) 14 (1.1) 13 (0.7) 12 (1.3)
Neutral 232 (8.6) 100 (7.3) 132 (10) 117 (6.6) 115 (12.4)
Agree 1,251 (46.5) 666 (48.8) 585 (44.1) 812 (46) 439 (47.4)
Strongly agree 1,124 (41.7) 561 (41.1) 563 (42.4) 790 (44.7) 334 (36.1)
Enhanced my ability to converse
with my medical team.
2,680
Strongly disagree 63 (2.4) 30 (2.2) 33 (2.5) .333a 36 (2) 27 (2.9) < .001a
Disagree 28 (1) 9 (0.7) 19 (1.4) 18 (1) 10 (1.1)
Neutral 275 (10.3) 117 (8.6) 158 (12.0) 140 (8) 135 (14.7)
Agree 1,314 (49) 702 (51.7) 612 (46.3) 864 (49.1) 450 (49)
Strongly agree 1,000 (37.3) 501 (36.9) 499 (37.8) 703 (39.9) 297 (32.3)




Strongly disagree 65 (2.4) 29 (2.2) 36 (2.7) .971a 39 (2.2) 26 (2.8) < .001a
Disagree 29 (1.1) 12 (0.9) 17 (1.3) 17 (1) 12 (1.3)
Neutral 254 (9.5) 125 (9.3) 129 (9.8) 153 (8.7) 101 (11)
Agree 1,187 (44.4) 617 (45.7) 570 (43.2) 747 (42.6) 440 (48)
Strongly agree 1,136 (42.5) 568 (42) 568 (43) 799 (45.5) 337 (36.8)
Made me feel more in control of
my medical decisions.
2691
Strongly disagree 62 (2.3) 26 (1.9) 36 (2.7) .410a 38 (2.2) 24 (2.6) .006a
Disagree 44 (1.6) 18 (1.3) 26 (2) 31 (1.8) 13 (1.4)
Neutral 356 (13.2) 185 (13.6) 171 (12.9) 217 (12.3) 139 (15.1)
Agree 1,222 (45.4) 644 (47.2) 578 (43.6) 791 (44.7) 431 (46.8)
Strongly agree 1,007 (37.4) 491 (36) 516 (38.9) 693 (39.2) 314 (34.1)
Made me more comfortable to
pursue treatment.
686
Strongly disagree 10 (1.5) 6 (1.6) 4 (1.3) .290a 8 (1.7) 2 (0.9) .706a
Disagree 24 (3.5) 9 (2.5) 15 (4.7) 18 (3.8) 6 (2.8)
Neutral 122 (17.8) 68 (18.5) 54 (16.9) 89 (18.9) 33 (15.4)
Agree 291 (42.4) 167 (45.5) 124 (38.9) 189 (40) 102 (47.7)
Strongly agree 239 (34.8) 117 (31.9) 122 (38.2) 168 (35.6) 71 (33.2)
Played a part in my decision to
pursue treatment.
671
Strongly disagree 36 (5.4) 18 (5) 18 (5.7) .084a 26 (5.6) 10 (4.8) .472a
Disagree 93 (13.9) 52 (14.6) 41 (13.1) 62 (13.4) 31 (14.8)
Neutral 187 (27.9) 111 (31.1) 76 (24.2) 128 (27.7) 59 (28.2)
Agree 197 (29.4) 101 (28.3) 96 (30.6) 130 (28.1) 67 (32.1)
Strongly agree 158 (23.6) 75 (21) 83 (26.4) 116 (25.1) 42 (20.1)
Note: IUI ¼ intrauterine insemination; IVF ¼ in vitro fertilization; OI ¼ ovulation induction.
a Wilcoxon rank sum tests were conducted to examine the difference in median response ranks between two groups.
Madeira. Informed consent with multimedia platform. Fertil Steril 2018.
1342 VOL. 110 NO. 7 / DECEMBER 2018
ORIGINAL ARTICLE: ETHICS
for statistical tests was set at a¼ .05 (two-tailed). Participants'
descriptive characteristics were presented as numbers and
percentages. Categorical data analyses were used to examine
the statistically significant associations between participants'
types (or treatment types) and participants' comprehension
and satisfaction related to the multimedia platform using
the chi-square test. For questions with ordinal responses
(i.e., strongly disagree to strongly agree), Wilcoxon rank
sum tests were used to compare the levels of agreement
with the multimedia platform for the informed consent
process.
RESULTS
A total of 3,097 patients/partners (49% of 6,333 survey ques-
tionnaires) who completed the multimedia platforms and
answered the five key questions were analyzed, comprising
2,046 (66%) IVF modules and 1,051 (34%) OI-IUI treatment
modules. Because this study did not track the respondents'
progress through medical treatment, including whether they
ultimately completed an ART procedure, it is unknown how
many or which patients who completed the platform and
the survey did not complete a cycle. The completed surveys
included 1,554 (50%) respondents whose partners did not
take the survey and 1,543 (50%) respondents who completed
the survey with their partner. In general, the majority of re-
spondents—3,056 (99%) of 3,097—felt that being properly
informed about their care was either important or very
important.
Overall, 2,472 (93%) of 2,661 patients felt the multimedia
platform was intuitive to use, 2,421 (90%) of 2,699 thought it
was of an appropriate length, and 2,553 (95%) of 2,699 found
it to have an appropriate level of detail. In addition, 2,382
(89.4%) of 2,663 patients stated that the comprehension ques-
tions helped reinforce key concepts. Also, 2,946 (96%) of
3,097 respondents liked learning about IVF or OI-IUI treat-
ment from the multimedia platform, and 3,001 (97%) of
3,097 participants felt its videos were a helpful addition to
consultations with their medical team; 1,528 (49%) of 3,097
participants felt it answered many questions that they other-
wise would have asked, and 1,390 (45%) of 3,097 found that it
answered one or a few questions. Furthermore, 2,323 (86%) of
2,693 patients agreed or strongly agreed that the multimedia
platform better prepared them to sign consent documents,
530 (77%) of 686 agreed or strongly agreed that it made
them more comfortable pursuing treatment, and 2,229
(83%) 2,691 agreed or strongly agreed that it improved their
satisfaction with their care.
In terms of identifying the most effective information
source, 1,542 (55%) of 2,800 patients ranked the physician
consultation highest, while 538 (19%) of 2,800 ranked the
multimedia platform as the most valuable. Patients did
not find the other sources as valuable; only 266 (10%) of
2,800 participants ranked Internet or website sources
most effective, and similar results were observed for in-
person nurse training (262 [9%] of 2,800) and printed ma-
terials (192 [7%] of 2,800).
Comparing the IVF and OI-IUI media platforms, no differ-
ences were observed regarding the patients' responses to
questions about intuitiveness of use, length, level of detail,
comfort level with pursuing treatment, or satisfaction with
care. Compared with the patients using the OI-IUI media plat-
form, however, significantly more respondents using the IVF
media platform strongly agreed that the comprehension ques-
tions helped reinforce key concepts (47% vs. 40%, P¼ .002),
educated them about treatment risks (55% vs. 44%,
P< .001), enhanced their ability to ask informed questions
of their medical team (45% vs. 36%, P< .001), better prepared
them to sign informed consent forms (46% vs. 37%, P< .001),
enhanced their control over medical decisionmaking (39% vs.
34%, P¼ .006), were helpful additions to medical team con-
sultations (98% vs. 96%, P¼ .002), and answered many ques-
tions that patients would otherwise have asked their medical
team (56% vs. 37%, P< .001) (see Table 1). No differences
were noted between the patients who used the platform alone
and those who used it with partners. Similarly, no clinically
relevant differences were noted when stratified by academic
versus private clinics, geographic location, or program size
(data not shown).
Providers' Perceptions of the Multimedia Platform
Twenty-six (63%) of 41 providers or nurses felt that the media
platform improved patient learning and understanding, made
patients more accountable, made patient education more effi-
cient, and allowed them to standardize and disseminate
comprehensive information. Overall, 28 (68%) of 41 felt it
saved up to 1 hour per patient that was usually spent address-
ing patients' questions and answering follow-up phone calls
and e-mails. Conversely, 7 (17%) of 41 felt the media platform
had some disadvantages, including generating more patient
conversations and questions, necessitating more follow-up
responsibilities, and introducing concern over exactly when
the platform should be implemented.
DISCUSSION
Our data suggest that a multimedia platform improves patient
education regarding ART treatment, gives patients more con-
trol over their medical decision making, and better prepares
them to participate in the consent process. Overall, the pa-
tients' responses suggested that this media platform may be
more beneficial for those undergoing IVF. Furthermore, it is
also well-liked by providers and nurses, and is easily
implemented.
Although informed consent documents are the most
frequently used informational aid, they have several inherent
weaknesses. As consent forms are often lengthy, patients
might be tempted to skim the documents rather than read
them carefully (9, 10). Given the complexity of the
documents, patients may have trouble deciphering the
technical or legal jargon, particularly if they have low
literacy or are non-native English speakers (11). Moreover,
informed consent is affected by psychosocial factors such as
satisfaction, happiness, and anxiety, which can also influence
knowledge retention and understanding (12, 13).
Multimedia platforms have several potential advantages
over informed consent documents, including the incorpora-
tion of audio narration along with visual cues, diagrams,
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and animations (4). This allows patients to more deeply
explore dynamic treatment processes in a more accurate,
engaging, and concise format than static images and/or
text. To date, such applications have been more widely devel-
oped and used in other medical specialties than in reproduc-
tive medicine.
Multimedia interventions can allow patients to customize
their educational and consent processes by clicking on
prompts to get more detailed information, and the applica-
tions can be tailored to fit individual learning styles (7). These
tools can incorporate quizzes and other tools that immedi-
ately reinforce information and give patients direct feedback.
Allowing physicians access to patients' quiz answers can help
medical teams to identify confusing topics they can clarify in
subsequent conversations (5, 10). Multimedia platforms can
also improve patients' communication with medical teams
through assets that allow patients to submit questions or
converse with providers in real time (5). Furthermore,
patients can access these platforms when it is most
convenient and comfortable, whereas the document-based
informed consent process traditionally takes place in a struc-
tured medical environment (4, 5).
Research concerning multimedia aids has generated
mixed results. Some empirical evaluations have concluded
that these applications can contribute to more active patient
learning and engagement, increased comprehension, and
more efficient use of time for patients and providers (5, 6);
however, other studies have demonstrated equivocal
outcomes when comparing multimedia platforms to
traditional consent documents.
Cohn and Larson (7) reviewed 980 multimedia informed
consent studies that evaluated documents, multimedia tools,
and in-person education to assess whether any particular me-
dium facilitated superior patient comprehension; they
concluded that no single medium was consistently associated
with improved comprehension and that a variety of methods
could be most efficacious (7). Randomized clinical trials have
also attempted to address these issues. Kass et al. (8) assessed
whether a computer-based intervention improved patient
comprehension relative to traditional consent documents
when describing oncologic early-phase research trials; they
found only minimal differences in patient understanding of
the trial's purpose and participation benefits when comparing
patients who were assigned to a computer-based intervention
with those who received documents. Jeste et al. (14) reported
that patient satisfaction with informational quality and aid
effectiveness was high for both patients who received tradi-
tional consent documents (P¼ .43) and those who received ac-
cess to a multimedia aid (P¼ .47).
Still other studies have suggested that face-to-face dis-
cussions appear to improve patient understanding more
than both multimedia platforms and traditional document
consent methods, and that the best approach might be to
combine multimedia tools with interpersonal discussion.
However, a few studies have documented a negative impact
associated with computer-based patient education, including
patient complaints that videos are more tedious, unnecessar-
ily long, emotionally distressing, or harder to use as compared
to consent documents (6, 15).
Finally, several studies have concluded that multimedia
platforms are effective educational and consent aids (9, 16–
18). A literature review of 66 studies assessing multimedia
interventions concluded that such tools were associated
with higher patient satisfaction with consent processes,
greater patient enjoyment, and improved comprehension
(6). Other studies comparing multimedia aids with consent
documents found statistically significantly higher
comprehension and satisfaction among patients assigned to
the multimedia intervention (16–18). Willis (11) found that
features of multimedia platforms such as brief quizzes and
pop-up screens may allow providers to more easily identify
obstacles in patient understanding that traditional documents
would not reveal.
These conflicting empirical results must be interpreted
with caution as several studies had limitations such as small
or unrepresentative samples, poor experimental design, lack
of blinding, and demographic differences between groups
(6, 15). Additionally, it is difficult to meaningfully compare
different multimedia interventions with respect to clarity,
animated versus photographic visuals, games, and quizzes.
There is even disagreement over what constitutes
‘‘comprehension’’ and how it should be measured (7, 9),
let alone gauging how to overcome challenges such as low
literacy and limited health knowledge (9). Studies assess
different outcomes and use different analytics or measures.
For example, some of them test recall but not patient
decision making, or they use cognitive interviewing but not
surveys. Finally, little research has assessed the patients'
psychological states at the time of consent, or investigated
how this factor impacts pretreatment information storage,
retention, and recall.
Our study is the first to empirically assess multimedia in-
terventions in ART informed consent processes and to
analyze a multimedia platform from both patient and pro-
vider perspectives. The multimedia platform assessed in this
study appears to have been designed with an eye to avoiding
problematic flaws such as overly long or complex videos. Pa-
tients identified several advantages of this multimedia plat-
form, including increased satisfaction (more individualized
experiences), efficacy (answering existing questions, better
use of patient time), convenience (completion at patient
discretion), information delivery (more details about treat-
ment procedures and risks), and improved patient–physician
communication (identifying questions to ask, better use of
appointment time). Patients' positive experiences may further
impact their overall satisfaction with their providers andmed-
ical care.
From the providers' and nurses' perspectives, the multi-
media platform improved patient learning and understand-
ing, made patients more accountable, enhanced efficient
patient education, and provided the ability to standardize
and disseminate comprehensive information. From a value
perspective, the majority felt it saved up to an hour per
patient.
It is noteworthy that the patients evaluated the IVF plat-
form more highly than the OI-IUI platform. This may be
because IVF is more complex than OI-IUI, and it requires
more explanation to understand. For this reason, patients
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may find the multimedia platform more useful in explaining
concepts regarding IVF compared with OI-IUI treatment
because it has visual aids depicting the additional proced-
ures such as intracytoplasmic sperm injection, preimplanta-
tion genetic diagnosis, or assisted hatching. However,
because the study was quantitative rather than qualitative,
further research will be needed to explore this relative
preference.
This study has several limitations, including the inability
to control for patient experiences before using the multimedia
platform (such as prior treatment cycles), the lack of a uniform
implementation protocol (completing the media platform
before versus after a physician consent conversation), and
no baseline assessments of patient knowledge regarding the
IVF or OI-IUI process. Given that demographic information
was not obtained, patients of varying ages (younger popula-
tions vs. older populations) may have differing views and
preferences regarding multimedia consenting and knowl-
edge; future studies may investigate these differences. In
addition, the survey did not assess how many respondents
completed the survey and underwent treatment versus how
many did not, which may have impacted the survey out-
comes. The strengths of our study included the anonymity
of the survey responses, which enhanced truthfulness, and
the survey's national distribution, which helped to achieve a
wide geographic distribution of patient values, attitudes,
and experiences.
There is an urgent need for more empirical investigation
of the impact of multimedia platforms on patient recall,
comprehension, satisfaction, treatment experience, and treat-
ment relationships. We are currently involved in a random-
ized, controlled trial comparing this media platform with
traditional consent documents in IVF and OI-IUI contexts.
Future research can clarify other questions, including identi-
fying when patients should complete the multimedia inter-
ventions, where they can use the multimedia platform most
effectively (at home or in clinical settings), and whether treat-
ment personnel should be available to assist with usage
difficulties.
Informed consent in ART presents unique ethical chal-
lenges and considerations for patients, partners, and pro-
viders. It requires active engagement from all parties but
places much of the burden of conveying material information
upon professionals. The educational value of the informed
consent process is also related to the quality of patient expe-
rience. Yet the consent process is too often conceptualized as
an adversarial, standardized, impersonal event instead of a
helpful ongoing dialogue within a care relationship (5). Multi-
media platforms represent an opportunity to improve the de-
livery of information in ways that accommodate many
learning styles; they can increase patient comprehension,
comfort, and communication with providers, and ensure
that accurate information is delivered in a standardized
format, preparing the patients for interpersonal consent con-
versations (1, 4).
In general, the EngagedMD multimedia platform yielded
perceived self-reported benefits for both patients and pro-
viders/nurses, potentially making the patients better informed
and the informed consent processes more efficient. As the
process of informed consent evolves, future research must
evaluate its impact upon patient recall and comprehension,
emotional dynamics, the patient–physician relationship,
and the best implementation timing.
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Uso de la plataforma multimedia EngagedMD para mejorar el consentimiento informado para la induccion de la ovulacion,
la inseminacion intrauterina y la fecundacion in vitro
Objetivo: estudiar las opiniones de los pacientes y los proveedores de salud sobre como una plataforma multimedia (EngagedMD)
ayuda a los pacientes a entender los riesgos y las consecuencias de los tratamientos de fecundacion in vitro (FIV), de induccion de
la ovulacion (IO) y de inseminacion artificial (IA) y el impacto del proceso de consentimiento informado.
Dise~no: estudio mediante encuesta prospectiva.
Entorno: unidades de FIV en los Estados Unidos.
Paciente(s): 6333 pacientes que vieron la plataformamultimedia antes del tratamiento de FIV o de IO-IA en 13 centros de FIV de EEUU
y 128 proveedores de salud.
Intervencion(es): encuesta cualitativa con 17 preguntas.
Medida(s) de resultado(s) principal(es): valoracion del impacto de una plataforma multimedia sobre la ansiedad, la comprension y la
satisfaccion del paciente y opinion del proveedor de salud/enfermera relacionada con el proceso de consentimiento informado.
Resultado(s): la encuesta fue completada 3.097 encuestados (66% tratamiento FIV; 34% tratamiento IO-IA) y 44 proveedores de salud.
En conjunto, el 93% encontraron que la plataforma multimedia era intuitiva y el 90% y el 95%, respectivamente, encontraron que tenía
una duracion apropiada y detallada. La mayoría estuvo de acuerdo omuy de acuerdo en que les preparaba para el consentimiento (88%),
en que aumentaba su comodidad para seguir con el tratamiento (77%) y en que aumentaba su satisfaccion con la atencionmedica (83%).
Comparado con el grupo IO-IA, de una forma estadísticamente significativa, mas participantes que vieron la plataforma multimedia de
FIV estuvieronmuy de acuerdo en que la comprension de las preguntas reforzo conceptos clave (47% vs. 40%), en que les educo sobre los
riesgos del tratamiento (55% vs. 44%), en que les ayudo a preguntar a sus proveedores de salud cuestiones informadas (45% vs. 36%) y
en que les preparo mejor para firmar los consentimientos informados (46% vs. 37%). En general, el 63% de los proveedores de salud
sintieron que la plataforma multimedia mejoro el aprendizaje de los pacientes, responsabilizo mas a los pacientes, y estandarizo la
difusion de la informacion.
Conclusion(es): La plataforma multimedia EngagedMD mejora en los pacientes el conocimiento, la satisfaccion y el control sobre la
toma de decisiones medicas y los prepara mejor para otorgar el consentimiento informado. Ademas, es muy apreciada por los provee-
dores de salud y facilmente implementada de los pacientes.
1346 VOL. 110 NO. 7 / DECEMBER 2018
ORIGINAL ARTICLE: ETHICS
